Literature DB >> 20881358

Mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal dysfunction by improving the antioxidant/oxidant balance in the ischemic kidney.

Wenli Zhuo1, Lianming Liao, Tingzhao Xu, Weizhen Wu, Shunliang Yang, Jianming Tan.   

Abstract

BACKGROUND: Renal ischemia followed by reperfusion leads to acute renal failure in both native kidneys and renal allograft. This study aimed at investigating the effects of mesenchymal stem cells (MSC) on ischemia/reperfusion (I/R) injury and the underlying mechanisms in a rat model.
METHODS: Renal ischemia was produced by clamping the right renal vessels for 60 min after the left kidney was removed. Immediately after visual confirmation of reflow, 1 × 10(6) MSC were administered by intravenous injection, followed by reperfusion for 24 h. The kidney functions, tissue malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) levels were evaluated. Histopathological examinations were also performed.
RESULTS: MSC infusion significantly improved kidney function as indicated by lower urea and creatinine levels in the MSC compared to the vehicle group (p < 0.05). I/R-induced reduction in renal tissue SOD enzyme activity and GSH-Px was significantly improved by MSC (p < 0.05). Treatment with MSC also resulted in significant reduction in renal tissue MDA levels that were increased by renal I/R injury (p < 0.05). At histological examination, the kidneys of MSC-treated rats showed a fairly normal morphology.
CONCLUSIONS: MSC protects the kidneys against I/R injury at least via their antioxidant effects.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881358     DOI: 10.1159/000319366

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  21 in total

Review 1.  Regenerative medicine in kidney disease: where we stand and where to go.

Authors:  Fernanda T Borges; Nestor Schor
Journal:  Pediatr Nephrol       Date:  2017-07-22       Impact factor: 3.714

Review 2.  miR-21 in ischemia/reperfusion injury: a double-edged sword?

Authors:  Xialian Xu; Alison J Kriegel; Xiaoyan Jiao; Hong Liu; Xiaowen Bai; Jessica Olson; Mingyu Liang; Xiaoqiang Ding
Journal:  Physiol Genomics       Date:  2014-08-26       Impact factor: 3.107

Review 3.  Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells.

Authors:  Antoine Monsel; Ying-Gang Zhu; Stephane Gennai; Qi Hao; Jia Liu; Jae W Lee
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

Review 4.  In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury.

Authors:  Danilo C de Almeida; Cassiano Donizetti-Oliveira; Priscilla Barbosa-Costa; Clarice St Origassa; Niels Os Câmara
Journal:  Clin Biochem Rev       Date:  2013-11

5.  Intravenous Administration of Human Umbilical Cord Mesenchymal Stem Cells Improves Cognitive Impairments and Reduces Amyloid-Beta Deposition in an AβPP/PS1 Transgenic Mouse Model.

Authors:  Hui Yang; Caibin Yue; Hongna Yang; Zhaohong Xie; Hongzhen Hu; Lifei Wei; Ping Wang; Cuiping Zhao; Jianzhong Bi
Journal:  Neurochem Res       Date:  2013-09-29       Impact factor: 3.996

6.  Genetic modification of H2AX renders mesenchymal stromal cell-derived dopamine neurons more resistant to DNA damage and subsequent apoptosis.

Authors:  Peizhou Jiang; Peng Huang; Shu-Hui Yen; Abba C Zubair; Dennis W Dickson
Journal:  Cytotherapy       Date:  2016-10-06       Impact factor: 5.414

Review 7.  Emerging Therapeutic Potential of Mesenchymal Stem/Stromal Cells in Preeclampsia.

Authors:  S Suvakov; C Richards; V Nikolic; T Simic; K McGrath; A Krasnodembskaya; L McClements
Journal:  Curr Hypertens Rep       Date:  2020-04-14       Impact factor: 5.369

8.  Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.

Authors:  Taihei Suzuki; Masayuki Iyoda; Takanori Shibata; Hirokazu Ohtaki; Kei Matsumoto; Yuki Shindo-Hirai; Yoshihiro Kuno; Yukihiro Wada; Yasutaka Yamamoto; Mio Kawaguchi; Seiji Shioda; Tadao Akizawa
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

9.  The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats.

Authors:  Guangyuan Zhang; Xiangyu Zou; Shuai Miao; Jinjun Chen; Tao Du; Liang Zhong; Guanqun Ju; Guohua Liu; Yingjian Zhu
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

10.  Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions.

Authors:  Jie Hu; Li Zhang; Nan Wang; Rui Ding; Shaoyuan Cui; Fei Zhu; Yuansheng Xie; Xuefeng Sun; Di Wu; Quan Hong; Qinggang Li; Suozhu Shi; Xiaoluan Liu; Xiangmei Chen
Journal:  Kidney Int       Date:  2013-04-24       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.